Insulin treatment of nondiabetic patients with acute coronary syndrome (ACS) and hyperglycemia is associated with reduced risk of death in the first 30 days.
Read More »Diabetes In Control
Adults With Conditions that Increase Cardiovascular Disease Risk Have High Blood Pressure
Nearly three-fourths of American adults with conditions such as coronary heart disease, stroke, diabetes or others that raise their risk for cardiovascular complications also have hypertension (high blood pressure).
Read More »FDA Approves Diovan® for Treatment of High Blood Pressure in Children
Diovan® (valsartan), an angiotensin receptor blocker or ARB, has been approved following a priority review by the U.S. Food and Drug Administration (FDA) for the treatment of high blood pressure in children and adolescents ages six to 16.
Read More »Vinegar at Bedtime Can Benefit Type 2’s
A dose of vinegar taken at bedtime may favorably impact waking glucose concentrations in patients with type 2 diabetes, comes from the results of a new study.
Read More »Diabetes Linked to Blood Vessel Inflammation
U.S. researchers say they’ve identified a new pathway that increases a dangerous inflammation of blood vessels in people with diabetes.
Read More »Guidelines Revised for Management of Type 2 Diabetes
The American Diabetes Association and the European Association for the Study of Diabetes have issued a consensus statement on the management of hyperglycemia in type 2 diabetes.
Read More »Mediterranean Diet and Physical Activity Each Associated With Lower Death Rate
Eating a Mediterranean diet and following national recommendations for physical activity are each associated with a reduced risk of death over a five-year period, according to two reports.
Read More »Over Weight Kids Put Their Hearts at Risk
A new U.S. study finds that by the time today’s teens reach middle age, the rate of heart disease could be 16 percent higher because of the extra pounds they are carrying today.
Read More »Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control
FDA Submission for monotherapy will be submitted in the first half of 2008.
Read More »British Group Detests Testing —
I just got a message from Ronald Tamler, MD, PhD, MBA, CNSP that ought to get your dander up. The October issue of the Journal of Family Practice contains a bold (literally) statement: “Self-monitoring blood glucose had no effect on HbA1c over the course of a year among patients who …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.